Connacht Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-64,300
Closed -$1.89M 105
2021
Q2
$1.89M Sell
64,300
-11,500
-15% -$348K 0.81% 32
2021
Q1
$2.41M Sell
75,800
-33,300
-31% -$977K 0.53% 52
2020
Q4
$2.27M Buy
+109,100
New +$2.04M 1.08% 28

Other funds holding BHC

Connacht Asset Management's BHC Position: Q2 2022 in Review

Connacht Asset Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 59,043 shares — an estimated $825K sold.

Connacht Asset Management first reported a position in BHC in Q4 2020 and held it in 6 quarters. The position peaked at $2.65M in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Connacht Asset Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Connacht Asset Management sold 59,043 Bausch Health shares in Q2 2022, an estimated $825K.
  • Connacht Asset Management first reported a position in Bausch Health in Q4 2020 and held it in 6 quarters.
  • Connacht Asset Management's Bausch Health position peaked at $2.65M in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Connacht Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.